158:1 Use of Cannabis for Therapeutic Purposes; Qualifying Conditions. RSA 126-X:1, IX(a) is repealed and reenacted to read as follows:

IX.(a)(1) "Qualifying medical condition'' means the presence of:

(A) Cancer, glaucoma, positive status for human immunodeficiency virus, acquired immune deficiency syndrome, hepatitis C, amyotrophic lateral sclerosis, muscular dystrophy, Crohn's disease, multiple sclerosis, chronic pancreatitis, spinal cord injury or disease, traumatic brain injury, epilepsy, lupus, Parkinson's disease, Alzheimer's disease, ulcerative colitis, Ehlers-Danlos syndrome, or one or more injuries or conditions that has resulted in one or more qualifying symptoms under subparagraph (B); and

(B) A severely debilitating or terminal medical condition or its treatment that has produced at least one of the following: elevated intraocular pressure, cachexia, chemotherapy-induced anorexia, wasting syndrome, agitation of Alzheimer's disease, severe pain that has not responded to previously prescribed medication or surgical measures or for which other treatment options produced serious side effects, constant or severe nausea, moderate to severe vomiting, seizures, or severe, persistent muscle spasms; or

(2) "Qualifying medical condition" also means:

(A) Moderate to severe chronic pain.

(B) Severe pain that has not responded to previously prescribed medication or surgical measures or for which other treatment options produced serious side effects.

(C) Moderate or severe post-traumatic stress disorder.

158:2 Departmental Administration: Registry Identification Cards. Amend RSA 126-X:4, VI to read as follows:

VI. The department shall provide each applicant and each approved qualifying patient and designated caregiver a statement with the registry identification card explaining current federal law on the possession of cannabis and, that possession of a state registry identification card does not protect a person from federal criminal penalties, and that by using cannabis the qualifying patient may be subject to the denial of rights and privileges by federal agencies including, but not limited to, the loss of rights related to employment such as driving a commercial vehicle, the inability to pass a security clearance, and the right to own, possess, or purchase a firearm and/or ammunition. The statement shall be updated based on any relevant changes in federal law.

158:3 Effective Date. This act shall take effect 60 days after its passage.

Approved: June 28, 2017

Effective Date: August 27, 2017

158:1 Use of Cannabis for Therapeutic Purposes; Qualifying Conditions. RSA 126-X:1, IX(a) is repealed and reenacted to read as follows:

IX.(a)(1) "Qualifying medical condition'' means the presence of:

(A) Cancer, glaucoma, positive status for human immunodeficiency virus, acquired immune deficiency syndrome, hepatitis C, amyotrophic lateral sclerosis, muscular dystrophy, Crohn's disease, multiple sclerosis, chronic pancreatitis, spinal cord injury or disease, traumatic brain injury, epilepsy, lupus, Parkinson's disease, Alzheimer's disease, ulcerative colitis, Ehlers-Danlos syndrome, or one or more injuries or conditions that has resulted in one or more qualifying symptoms under subparagraph (B); and

(B) A severely debilitating or terminal medical condition or its treatment that has produced at least one of the following: elevated intraocular pressure, cachexia, chemotherapy-induced anorexia, wasting syndrome, agitation of Alzheimer's disease, severe pain that has not responded to previously prescribed medication or surgical measures or for which other treatment options produced serious side effects, constant or severe nausea, moderate to severe vomiting, seizures, or severe, persistent muscle spasms; or

(2) "Qualifying medical condition" also means:

(A) Moderate to severe chronic pain.

(B) Severe pain that has not responded to previously prescribed medication or surgical measures or for which other treatment options produced serious side effects.

(C) Moderate or severe post-traumatic stress disorder.

158:2 Departmental Administration: Registry Identification Cards. Amend RSA 126-X:4, VI to read as follows:

VI. The department shall provide each applicant and each approved qualifying patient and designated caregiver a statement with the registry identification card explaining current federal law on the possession of cannabis , that possession of a state registry identification card does not protect a person from federal criminal penalties, and that by using cannabis the qualifying patient may be subject to the denial of rights and privileges by federal agencies including, but not limited to, the loss of rights related to employment such as driving a commercial vehicle, the inability to pass a security clearance, and the right to own, possess, or purchase a firearm and/or ammunition. The statement shall be updated based on any relevant changes in federal law.

158:3 Effective Date. This act shall take effect 60 days after its passage.

Approved: June 28, 2017

Effective Date: August 27, 2017